Skip to main content
Log in

Enzyme-inducing drug combinations and their effects on liver microsomal enzyme activity in man

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The effect of 2 different drug combinations on liver microsomal activity was investigated in healthy volunteers by administering antipyrine 1200 mg and phenobarbitone 100 mg, or the same dose of antipyrine with rifampicin 600 mg daily for 14 days. The effect of rifampicin 1200 mg given for only 8 days was also studied. Before and after each drug regimen, estimates were made of the total body clearance of antipyrine, γ-glutamyl-transferase (γ-GT) and urinary excretion of 6-β-hydroxycortisol as in vivo parameters of liver microsomal enzyme activity. Following combined antipyrine and phenobarbitone administration, the antipyrine clearance was increased by 80%, after antipyrine with rifampicin by 128%, and after rifampicin alone by 104%. 6-β-hydroxycortisol, corrected for 17-hydroxycorticosteroids, increased from 2.6% to 8% following antipyrine plus phenobarbitone, from 4.4% to 27.9% following antipyrine plus rifampicin, and from 5.4% to 29.7% after rifampicin given alone. Based on previous studies, antipyrine given with phenobarbitone produced slightly more induction than phenobarbitone given alone. Following antipyrine 1200 mg with rifampicin 600 mg for 14 days a significantly greater increase in antipyrine clearance and 6-β-hydroxycortisol excretion was observed than when either drug was given alone.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Breckenridge AM (1975) Clinical implications of enzyme induction. In: Park DV (ed) Enzyme induction. Plenum Press, London, pp 273–301

    Google Scholar 

  • Breckenridge AM, Orme ML'E, Thorgeirsson SS, Davies DS, Brooks RK (1971) Drug interactions with warfarin: Studies with dichloralphenazone, chloral hydrate and phenazone (antipyrine). Clin Sci 40: 351–364

    Google Scholar 

  • Brodie BB, Axelrod J, Soberman R, Levy BB (1949) The estimation of antipyrine in biological materials. J Biol Chem 179: 25–29

    Google Scholar 

  • Danhof M, Krom DP, Breimer DD (1979) Studies on the different metabolic pathways of antipyrine in rats: influence of pheno barbital and 3-methyl-cholanthrene treatment. Xenobiotica 9: 695–702

    Google Scholar 

  • Ohnhaus EE, Martin J, Kinser J, Colombo JP (1977) Enzyme induction and renal function in man. Br J Clin Pharmacol 4: 33–37

    Google Scholar 

  • Ohnhaus EE, Park BK (1979) Measurement of urinary 6-β-hydroxycortisol excretion as an in vivo parameter in the clinical assessment of the microsomal enzyme-inducing capacity of antipyrine, phenobarbitone and rifampicin. Eur J Clin Pharmacol 15: 139–145.

    Google Scholar 

  • Orme ML'E, Davies L, Breckenridge AM (1974) Increased glucuronidation of bilirubin in man and rat by administration of antipyrine (phenazone). Clin Sci Mol Med 46: 511–518

    Google Scholar 

  • Miguet JP, Mavier P, Soussy CJ, Dhumeaux D (1977) Induction of hepatic microsomal enzymes after brief administration of rifampicin in man. Gastroenterology 72: 924–926

    Google Scholar 

  • Park BK (1978) A specific radioimmunoassay for 6-β-hydroxycortisol in human. J Steroid Biochem 9: 963–966

    Google Scholar 

  • Prescott LF (1969) Pharmacokinetic drug interactions. Lancet 2: 1239–1243

    Google Scholar 

  • Sachs L (1978) Statistische Auswertungsmethoden. Springer, Berlin Heidelberg New York

    Google Scholar 

  • Sanghvi A, Wight C, Parikh B, Desai H (1973) Urinary 17-hydroxycorticosteroid determination with p-hydrazinobenzene-sulfonic-acid-phosphoric-acid. Am J Clin Pathol 60: 684–690

    Google Scholar 

  • Szasz G (1969) A kinetic photometric method for serum-γ-glutamyl-transpeptidase. Clin Chem 15: 124–136

    Google Scholar 

  • Toverud EL, Boobis AR, Brodie MJ, Murray S, Bennett PN, Whitmarsh V, Davies DS (1981) Differential induction of antipyrine metabolism by rifampicin. Eur J Clin Pharmacol 21: 155–160

    Google Scholar 

  • Tredger JM, Smith HM, Powell-Jackson PR, Davis M, Williams R (1981) Effect of rifampicin on the mouse hepatic mixed-function oxidase system. Biochem Pharmacol 30: 1043–1051

    Google Scholar 

  • Vesell ES (1979) The antipyrine test in clinical pharmacology: Conceptions and misconceptions. Clin Pharmacol Ther 26: 275–286

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ohnhaus, E.E., Gerber-Taras, E. & Park, B.K. Enzyme-inducing drug combinations and their effects on liver microsomal enzyme activity in man. Eur J Clin Pharmacol 24, 247–250 (1983). https://doi.org/10.1007/BF00613826

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00613826

Key words

Navigation